Theratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth
September 12, 2022 07:30 ET
|
Theratechnologies
Researchers report superior anticancer activity against cancer stem-like cells with TH1902, compared to unconjugated docetaxelFirst evidence for TH1902 targeting of human breast and ovarian cancer...
LAMEA Peptide Therapeutics Market Report 2022: Prevalence of Aids, Tuberculosis, Malaria, Gastroenteritis, and Hypertension Driving Growth in African Segment
August 09, 2022 04:58 ET
|
Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By...
Global Peptide Therapeutics Market Report 2022-2026 Featuring Novartis International, GlaxoSmithKline, Bristol Myers Squibb, Amgen, Eli Lilly and Co & PolyPeptide Group
July 28, 2022 05:48 ET
|
Research and Markets
Dublin, July 28, 2022 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with...
Global Peptide Therapeutics Markets Report 2022-2028 Featuring Teva Pharma, Takeda Pharma, Sanofi, Pfizer, Novartis, GlaxoSmithKline, Hoffmann-La Roche, Eli Lilly and Co, Bachem, & Amgen
June 28, 2022 05:43 ET
|
Research and Markets
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's...
Global Peptide Therapeutics Clinical Trials to 2028: Focus on Glucagon-like Peptides, Glycopeptides, Oligopeptides, Lipopeptides, Dipeptides, Opioid, Neuropeptides and Bicyclic Peptides
May 09, 2022 06:28 ET
|
Research and Markets
Dublin, May 09, 2022 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The global peptide...
The peptide therapeutics contract API manufacturing market is anticipated to grow at an annualized rate of 13.6%, claims Roots Analysis
April 07, 2022 09:30 ET
|
Roots Analysis
London, April 07, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Peptide Therapeutics: Contract API Manufacturing Market (2nd Edition), 2022-2035” report to its list of...
Peptide Therapeutics: Contract API Manufacturing Market Report 2022-2035 with Amgen, Eli Lilly, GlaxoSmithKline, Novo Nordisk and Takeda Dominating Among Others
March 24, 2022 05:38 ET
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics: Contract API Manufacturing Market by Scale of Operation, Type of Synthesis Method Used, Company Size, and Key Geographical...
Global Peptide Therapeutics Industry and Competitive Landscape Analytics 2021-2026 Featuring Profiles of Major Vendors, Including Teva Pharma, Novo Nordisk, Eli Lilly, Takeda Pharma, and GSK
October 15, 2021 04:43 ET
|
Research and Markets
Dublin, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market by Application, Drug Type, Type of Manufacturing, Synthesis Technology, Solid Phase Peptide Synthesis, and Hybrid...
Global Peptide Therapeutics Markets, 2021-2026 - New Drug Discovery and Product Launches in Chronic Metabolic Disorders Would Provide Fruitful Opportunities
October 05, 2021 07:08 ET
|
Research and Markets
Dublin, Oct. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market (2021 Edition) - Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced),...
Global Peptide Drug Conjugate Market Opportunity 2026 US Europe Japan South Korea Sales Forecast 2026
April 17, 2021 05:09 ET
|
KuicK Research
DELHI, India, April 17, 2021 (GLOBE NEWSWIRE) -- Global Peptide Drug Conjugate Market and Clinical Trials Insight 2026 Report Highlights: First FDA Approved Peptide Drug Conjugate: Pepaxto...